Translational Research
Volume 152, Issue 6 , Pages 257-264, December 2008

Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection

Departments of Pulmonary and Critical Care Medicine, Microbiology/Immunology, Preventive Medicine, and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Ill, the Division of Pulmonary Medicine, Children's Memorial Hospital, Chicago, Ill, and the Department of Pediatrics and Infectious Diseases, Shaare-Zedek Medical Center, Jerusalem, Israel

Received 17 July 2008; received in revised form 24 September 2008; accepted 6 October 2008. published online 03 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the Cystic Fibrosis Foundation Therapeutics, Inc. (to A.R.H.), Grant K02 AI065615 from the National Institutes of Health (to A.R.H.), Grant NHLBI/NCRR 1K12RR017707-02 (to M.J.), and Grant M01 RR-00048 (to M.J.).

PII: S1931-5244(08)00244-2

doi:10.1016/j.trsl.2008.10.003

Translational Research
Volume 152, Issue 6 , Pages 257-264, December 2008

Article Tools

* Image Usage & Resolution